Current Liabilities

Deferred Revenue

Medtronic Deferred Revenue increased by 33.3% to $400.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $400.00M to $400.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ3 2026Feb 24, 2026

How to read this metric

An increase is generally positive, signaling strong future demand and cash collection, while a decrease indicates the fulfillment of obligations.

Detailed definition

This represents payments received from customers for goods or services that have not yet been delivered or performed. It...

Peer comparison

Common in subscription and long-term contract businesses; highly indicative of future revenue visibility.

Metric ID: deferred_revenue_current

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$1.20B$1.10B$1.00B$801.00M$719.00M$662.00M$600.00M$500.00M$500.00M$400.00M$400.00M$400.00M$400.00M$300.00M$400.00M
QoQ Change-8.3%-9.1%-19.9%-10.2%-7.9%-9.4%-16.7%+0.0%-20.0%+0.0%+0.0%+0.0%-25.0%+33.3%
YoY Change-33.3%-34.6%-33.8%-25.1%-30.5%-24.5%-33.3%-20.0%-20.0%+0.0%-25.0%+0.0%
Range$300.00M$1.20B
CAGR-26.9%
Avg YoY Growth-23.3%
Median YoY Growth-25.0%

Frequently Asked Questions

What is Medtronic's deferred revenue?
Medtronic (MDT) reported deferred revenue of $400.00M in Q4 2025.
How has Medtronic's deferred revenue changed year-over-year?
Medtronic's deferred revenue decreased by 0.0% year-over-year, from $400.00M to $400.00M.
What does deferred revenue mean?
Cash received from customers for work that has not yet been completed.